Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro
Fulin Nian, Zhu Chen, Nuyun Jin, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 669, pp. 134-142
Closed Access | Times Cited: 21

Showing 21 citing articles:

Amorphous silica nanoparticles and the human gut microbiota: a relationship with multiple implications
Massimiliano G. Bianchi, Martina Chiu, Giuseppe Taurino, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics
Vineet Singh, Kanika Mahra, Da-Ryung Jung, et al.
Probiotics and Antimicrobial Proteins (2024) Vol. 16, Iss. 5, pp. 1744-1761
Closed Access | Times Cited: 5
Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis
Jae Woong Jang, Emma Capaldi, Tracy L. Smith, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Multi-omics reveals the mechanism of Trimethylamine N-oxide derived from gut microbiota inducing liver fatty of dairy cows
Chenlei Li, Feifei Wang, Yongxia Mao, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Irpex lacteus metabolites ameliorate hyperlipidemic mice via CYP7A1/HMGCR/FXR/AMPK signalling pathways and gut microbiota
Xuan Zhang, Yanye Wei, Jincheng Wu, et al.
Food Bioscience (2025), pp. 106294-106294
Closed Access
Intestinal microbiota promoted NiONPs-induced liver fibrosis via effecting serum metabolism
Jiarong Tang, Hongjun Zhao, Kun Li, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 270, pp. 115943-115943
Open Access | Times Cited: 3
Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis
Xue Li, Xinyi Xu, Sian Tao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Edible bird's nest regulates glucose and lipid metabolic disorders via the gut–liver axis in obese mice
Wei Zhang, Meizhen Zhu, Xuncai Liu, et al.
Food & Function (2024) Vol. 15, Iss. 14, pp. 7577-7591
Open Access | Times Cited: 2
Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis
Xingming Xie, Shu Feng, Tao Liu, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112747-112747
Open Access | Times Cited: 2
Trimethylamine N-oxide promotes the proliferation and migration of hepatocellular carcinoma cell through the MAPK pathway
Chunfang Zhou, Rina Basnet, Chenxiang Zhen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Postbiotic impact on host metabolism and immunity provides therapeutic potential in metabolic disease
Han Fang, Rodrigo Rodrigues e‐Lacerda, Nicole G. Barra, et al.
Endocrine Reviews (2024)
Open Access | Times Cited: 2
Effect of three oral pathogens on the TMA-TMAO metabolic pathway
Xixuan Wang, Liyuan Chen, Teng Ye, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Therapeutic manipulation of the microbiome in liver disease
Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan S. Bajaj
Hepatology (2024)
Closed Access | Times Cited: 1
Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells
Vinícius Marques Arruda, G. Azevedo, Maria Júlia Maia Gonçalves Granato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9591-9591
Open Access | Times Cited: 1
Investigation of the regulatory mechanisms of Guiqi Yimu Powder on dairy cow fatty liver cells using a multi-omics approach
Chenlei Li, Feifei Wang, Yanfen Ma, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
Multi-omics reveals the effects of dietary supplementation with Bupleuri radix branch powder on gut microbiota and lipid metabolism: insights into gut microbial-muscle interactions
Haiyan Li, Cheng Pan, Fuqiang Wang, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
An extended strategy of “Recursive Tree” for characterization of drug metabolites in vivo and in vitro and actional mechanism study based on network Pharmacology: Formononetin as a study case
Yanan Li, Shaoping Wang, Hong Wang, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 5, pp. 105761-105761
Open Access
Multi-omics reveals the mechanism of Trimethylamine N-oxide derived from gut microbiota inducing liver fatty of dairy cows
Chenlei Li, Feifei Wang, Yongxia Mao, et al.
Research Square (Research Square) (2024)
Closed Access
Low-Molecular-Weight Compounds Produced by the Intestinal Microbiota and Cardiovascular Disease
Lorena Cuervo, Patrick L. McAlpine, Carlos Olano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10397-10397
Open Access
The effect of anti‐imbalance on glycolipid metabolic homeostasis via the liver–gut axis intervened by 3′‐sialyllactose in obese mice
Wei Zhang, Meizhen Zhu, Kelsang Dekyi, et al.
Food Frontiers (2024)
Open Access
Current Status of Research on Cardiovascular Risk in Patients with Non-Alcoholic Fatty Liver Disease
·巴哈提 娜迪热
Advances in Clinical Medicine (2023) Vol. 13, Iss. 11, pp. 17451-17457
Closed Access
Page 1

Scroll to top